litlas
ログインアカウント作成

Steven P. Treon

1996–2026 年に発表

別表記
Steven P Treon
175
論文数
28,414
被引用数
97
h 指数
164
i10 指数

被引用数

Steven P. Treon の年別被引用数1997 年: 被引用 1 件1998 年: 被引用 9 件1999 年: 被引用 8 件2000 年: 被引用 21 件2001 年: 被引用 46 件2002 年: 被引用 119 件2003 年: 被引用 215 件2004 年: 被引用 186 件2005 年: 被引用 191 件2006 年: 被引用 170 件2007 年: 被引用 237 件2008 年: 被引用 241 件2009 年: 被引用 178 件2010 年: 被引用 237 件2011 年: 被引用 165 件2012 年: 被引用 112 件2013 年: 被引用 203 件2014 年: 被引用 193 件2015 年: 被引用 209 件2016 年: 被引用 185 件2017 年: 被引用 193 件2018 年: 被引用 282 件2019 年: 被引用 613 件2020 年: 被引用 883 件2021 年: 被引用 817 件2022 年: 被引用 603 件2023 年: 被引用 401 件2024 年: 被引用 695 件2025 年: 被引用 321 件2026 年: 被引用 22 件

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,118 件、この内訳の 30.9%中国: 引用元論文 511 件、この内訳の 7.5%イタリア: 引用元論文 466 件、この内訳の 6.8%ドイツ: 引用元論文 401 件、この内訳の 5.9%イギリス: 引用元論文 368 件、この内訳の 5.4%フランス: 引用元論文 352 件、この内訳の 5.1%スペイン: 引用元論文 250 件、この内訳の 3.7%オランダ: 引用元論文 208 件、この内訳の 3%日本: 引用元論文 179 件、この内訳の 2.6%カナダ: 引用元論文 165 件、この内訳の 2.4%オーストラリア: 引用元論文 160 件、この内訳の 2.3%スイス: 引用元論文 147 件、この内訳の 2.1%
0%30.9%その他 22.3%

機関

分野

  • Medicine64.6%
  • Biochemistry, Genetics and Molecular Biology25.9%
  • Immunology and Microbiology7.7%
  • Chemistry0.5%
  • Computer Science0.4%
  • Pharmacology, Toxicology and Pharmaceutics0.2%
  • その他0.7%

トピック

  • Chronic Lymphocytic Leukemia Research8.2%
  • Multiple Myeloma Research and Treatments8.1%
  • Lymphoma Diagnosis and Treatment7.9%
  • Protein Degradation and Inhibitors5.5%
  • Ubiquitin and proteasome pathways4.3%
  • Immune Cell Function and Interaction2.8%
  • その他63.2%

共著者

全論文

検索で開く
  1. The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee

    著者: Elı́as Campo, Elaine S. Jaffe, James R. Cook, Leticia Quintanilla‐Martínez, Steven H. Swerdlow, Kenneth C. Anderson, Pierre Brousset, Lorenzo Cerroni, Laurence de Leval, Stefan Dirnhofer, Ahmet Doǧan, Andrew L. Feldman, Falko Fend, Jonathan W. Friedberg, Philippe Gaulard, Paolo Ghia, Steven M. Horwitz, Rebecca L. King, Gilles Salles, Jesús F. San Miguel, John F. Seymour, Steven P. Treon, Julie M. Vose, Emanuele Zucca, Ranjana H. Advani, Stephen M. Ansell, Wing-Yan Au, Carlos Barrionuevo, Leif Bergsagel, Wing C. Chan, Jeffrey I. Cohen, Francesco d’Amore, Andrew Davies, Brunangelo Falini, Irene M. Ghobrial, John R. Goodlad, John G. Gribben, Eric D. Hsi, Brad S. Kahl, Won-Seog Kim, Shaji Kumar, Ann S. LaCasce, Camille Laurent, Georg Lenz, John P. Leonard, Michael P. Link, Armando López‐Guillermo, María‐Victoria Mateos, Elizabeth Macintyre, Ari Melnick, Franck Morschhauser, Shigeo Nakamura, Marina Narbaitz, Astrid Pavlovsky, Stefano Pileri, Miguel Á. Piris, Barbara Pro, S. Vincent Rajkumar, Steven T. Rosen, Birgitta Sander, Laurie H. Sehn, Margaret A. Shipp, Sonali M. Smith, Louis M. Staudt, Catherine Thieblemont, Thomas Tousseyn, Wyndham H. Wilson, Tadashi Yoshino, Pier Luigi Zinzani, Martin Dreyling, David W. Scott, Jane N. Winter, Andrew D. Zelenetz - Blood 2022 被引用: 1,506

  2. A Chemoproteomic Approach to Query the Degradable Kinome Using a Multi-kinase Degrader

    著者: Hai‐Tsang Huang, Dennis Dobrovolsky, Joshiawa Paulk, Guang Yang, Ellen Weisberg, Zainab M. Doctor, Dennis L. Buckley, Joong-Heui Cho, Eunhwa Ko, Jaebong Jang, Kun Shi, Hwan Geun Choi, James D. Griffin, Ying Li, Steven P. Treon, Eric S. Fischer, James E. Bradner, Li Tan, Nathanael S. Gray - Cell chemical biology 2017 被引用: 441

  3. Ibrutinib in Previously Treated Waldenström’s Macroglobulinemia

    著者: Steven P. Treon, Christina Tripsas, Kirsten Meid, Diane Warren, Gaurav Varma, Rebecca Green, Kimon V. Argyropoulos, Guang Yang, Yang Cao, Lian Xu, Christopher J. Patterson, Scott J. Rodig, James L. Zehnder, Jon C. Aster, Nancy L. Harris, Sandra Kanan, Irene M. Ghobrial, Jorge J. Castillo, Jacob P. Laubach, Zachary R. Hunter, Zeena Salman, Jianling Li, Mei Cheng, Fong Clow, Thorsten Graef, M. Lia Palomba, Ranjana H. Advani - New England Journal of Medicine 2015 被引用: 931

  4. Genomic profiling for clinical decision making in lymphoid neoplasms

    著者: Laurence de Leval, Ash A. Alizadeh, P. Leif Bergsagel, Elı́as Campo, Andrew Davies, Ahmet Doǧan, Jude Fitzgibbon, Steven M. Horwitz, Ari Melnick, William G. Morice, Ryan D. Morin, Bertrand Nadel, Stefano Pileri, Richard Rosenquist, Davide Rossi, Itziar Salaverría, Christian Steidl, Steven P. Treon, Andrew D. Zelenetz, Ranjana H. Advani, Carl E. Allen, Stephen M. Ansell, Wing C. Chan, James R. Cook, Lucy Cook, Francesco d’Amore, Stefan Dirnhofer, Martin Dreyling, Kieron Dunleavy, Andrew L. Feldman, Falko Fend, Philippe Gaulard, Paolo Ghia, John G. Gribben, Olivier Hermine, Daniel J. Hodson, Eric D. Hsi, Giorgio Inghirami, Elaine S. Jaffe, Kennosuke Karube, Keisuke Kataoka, Wolfgang Hiddemann, Won Seog Kim, Rebecca L. King, Young Hyeh Ko, Ann S. LaCasce, Georg Lenz, José I. Martín‐Subero, Miguel Á. Piris, Stefania Pittaluga, Laura Pasqualucci, Leticia Quintanilla‐Martínez, Scott J. Rodig, Andreas Rosenwald, Gilles Salles, Jesús F. San Miguel, Kerry J. Savage, Laurie H. Sehn, Gianpietro Semenzato, Louis M. Staudt, Steven H. Swerdlow, Constantine S. Tam, Judith Trotman, Julie M. Vose, Oliver Weigert, Wyndham H. Wilson, Jane N. Winter, Catherine J. Wu, Pier Luigi Zinzani, Emanuele Zucca, Adam Bagg, David W. Scott - Blood 2022 被引用: 161

  5. MYD88 L265P Somatic Mutation in Waldenström's Macroglobulinemia

    著者: Steven P. Treon, Lian Xu, Guang Yang, Yangsheng Zhou, Xia Liu, Yang Cao, Patricia Sheehy, Robert Manning, Christopher J. Patterson, Christina Tripsas, Luca Arcaini, Geraldine S. Pinkus, Scott J. Rodig, Aliyah R. Sohani, Nancy L. Harris, Jason M. Laramie, Donald A. Skifter, Stephen E. Lincoln, Zachary R. Hunter - New England Journal of Medicine 2012 被引用: 1,276

  6. Bruton tyrosine kinase degradation as a therapeutic strategy for cancer

    著者: Dennis Dobrovolsky, Eric S. Wang, Sara Morrow, Catharine Leahy, T.B. Faust, Radosław P. Nowak, Katherine A. Donovan, Guang Yang, Zhengnian Li, Eric S. Fischer, Steven P. Treon, David M. Weinstock, Nathanael S. Gray - Blood 2018 被引用: 169

  7. Zanubrutinib Versus Ibrutinib in Symptomatic Waldenström Macroglobulinemia: Final Analysis From the Randomized Phase III ASPEN Study

    著者: Meletios Α. Dimopoulos, Stephen Opat, Shirley D’Sa, Wojciech Jurczak, Hui‐Peng Lee, Gavin Cull, Roger G. Owen, Paula Marlton, Björn E. Wahlin, Ramón García‐Sánz, Helen McCarthy, Stephen P. Mulligan, Alessandra Tedeschi, Jorge J. Castillo, Jarosław Czyż, Carlos Fernández de Larrea, David Belada, Edward N. Libby, Jeffrey Matous, Marina Motta, Tanya Siddiqi, Monica Tani, Marek Trněný, Monique C. Minnema, Christian Buske, Véronique Leblond, Steven P. Treon, Judith Trotman, Wai‐Yee Chan, Jingjing Schneider, Heather Allewelt, Sheel Patel, Aileen Cohen, Constantine S. Tam - Journal of Clinical Oncology 2023 被引用: 103

  8. Elevated IL-17 produced by Th17 cells promotes myeloma cell growth and inhibits immune function in multiple myeloma

    著者: Rao Prabhala, Dheeraj Pelluru, Mariateresa Fulciniti, Harsha Prabhala, Puru Nanjappa, Weihua Song, Christine Pai, Samir Amin, Yu‐Tzu Tai, Paul G. Richardson, Irene M. Ghobrial, Steven P. Treon, John Daley, Kenneth C. Anderson, Jeffery L. Kutok, Nikhil C. Munshi - Blood 2010 被引用: 346

  9. The genomic landscape of Waldenström macroglobulinemia is characterized by highly recurring MYD88 and WHIM-like CXCR4 mutations, and small somatic deletions associated with B-cell lymphomagenesis

    著者: Zachary R. Hunter, Lian Xu, Guang Yang, Yangsheng Zhou, Xia Liu, Yang Cao, Robert Manning, Christina Tripsas, Christopher J. Patterson, Patricia Sheehy, Steven P. Treon - Blood 2013 被引用: 480

  10. Clinicopathological definition of Waldenstrom's macroglobulinemia: Consensus Panel Recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia

    著者: Roger G. Owen, Steven P. Treon, Ayad Al‐Katib, Rafaël Fonseca, Philip R. Greipp, Mary L. McMaster, Enrica Morra, Gerassimos A. Pangalis, Jesús F. San Miguel, Andrew R. Branagan, Meletios Α. Dimopoulos - Seminars in Oncology 2003 被引用: 918

  11. Thalidomide and immunomodulatory derivatives augment natural killer cell cytotoxicity in multiple myeloma

    著者: Faith E. Davies, Noopur Raje, Teru Hideshima, Suzanne Lentzsch, Gloria Young, Yu‐Tzu Tai, Boris K. Lin, Klaus Podar, Deepak Gupta, Dharminder Chauhan, Steven P. Treon, Paul G. Richardson, Robert Schlossman, Gareth J. Morgan, George W. Muller, David Stirling, Kenneth C. Anderson - Blood 2001 被引用: 905

  12. Phase 3 Trial of Ibrutinib plus Rituximab in Waldenström’s Macroglobulinemia

    著者: Meletios Α. Dimopoulos, Alessandra Tedeschi, Judith Trotman, Ramón García‐Sánz, D. Blair Macdonald, Véronique Leblond, Beatrice Mahé, Charles Herbaux, Constantine S. Tam, Lorella Orsucci, M. Lia Palomba, Jeffrey Matous, Chaim Shustik, Efstathios Kastritis, Steven P. Treon, Jianling Li, Zeena Salman, Thorsten Graef, Christian Buske - New England Journal of Medicine 2018 被引用: 350

  13. A mutation in MYD88 (L265P) supports the survival of lymphoplasmacytic cells by activation of Bruton tyrosine kinase in Waldenström macroglobulinemia

    著者: Guang Yang, Yangsheng Zhou, Xia Liu, Lian Xu, Yang Cao, Robert Manning, Christopher J. Patterson, Sara J. Buhrlage, Nathanael S. Gray, Yu‐Tzu Tai, Kenneth C. Anderson, Zachary R. Hunter, Steven P. Treon - Blood 2013 被引用: 347

  14. Somatic mutations in MYD88 and CXCR4 are determinants of clinical presentation and overall survival in Waldenström macroglobulinemia

    著者: Steven P. Treon, Yang Cao, Lian Xu, Guang Yang, Xia Liu, Zachary R. Hunter - Blood 2014 被引用: 381

  15. Long-Term Follow-Up of Ibrutinib Monotherapy in Symptomatic, Previously Treated Patients With Waldenström Macroglobulinemia

    著者: Steven P. Treon, Kirsten Meid, Joshua Gustine, Guang Yang, Lian Xu, Xia Liu, Christopher J. Patterson, Zachary R. Hunter, Andrew R. Branagan, Jacob P. Laubach, Irene M. Ghobrial, M. Lia Palomba, Ranjana H. Advani, Jorge J. Castillo - Journal of Clinical Oncology 2020 被引用: 150

  16. CXCR4 in Waldenström’s Macroglobulinema: chances and challenges

    著者: Lisa Kaiser, Zachary R. Hunter, Steven P. Treon, Christian Buske - Leukemia 2020 被引用: 91

  17. Genomic Landscape of Waldenström Macroglobulinemia and Its Impact on Treatment Strategies

    著者: Steven P. Treon, Lian Xu, Maria Luisa Guerrera, Cristina Jiménez, Zachary R. Hunter, Xia Liu, Maria Demos, Joshua Gustine, Gloria Chan, Manit Munshi, Nicholas Tsakmaklis, Jiaji G. Chen, Amanda Kofides, Romanos Sklavenitis‐Pistofidis, Mark Bustoros, Andrew Keezer, Kirsten Meid, Christopher J. Patterson, Antonio Sacco, Aldo M. Roccaro, Andrew R. Branagan, Guang Yang, Irene M. Ghobrial, Jorge J. Castillo - Journal of Clinical Oncology 2020 被引用: 165

  18. Ibrutinib Plus Rituximab Versus Placebo Plus Rituximab for Waldenström's Macroglobulinemia: Final Analysis From the Randomized Phase III iNNOVATE Study

    著者: Christian Buske, Alessandra Tedeschi, Judith Trotman, Ramón García‐Sánz, David MacDonald, Véronique Leblond, Beatrice Mahé, Charles Herbaux, Jeffrey Matous, Constantine S. Tam, Leonard T. Heffner, Marzia Varettoni, M. Lia Palomba, Chaim Shustik, Efstathios Kastritis, Steven P. Treon, Jerry Ping, Bernhard Hauns, Israel Arango‐Hisijara, Meletios A. Dimopoulos - Journal of Clinical Oncology 2021 被引用: 113

  19. Molecular sequelae of proteasome inhibition in human multiple myeloma cells

    著者: Nicholas Mitsiades, Constantine Mitsiades, Vassiliki Poulaki, Dharminder Chauhan, Galinos Fanourakis, Xuesong Gu, Charles C. Bailey, Marie Joseph, Towia A. Libermann, Steven P. Treon, Nikhil C. Munshi, Paul G. Richardson, Teru Hideshima, Kenneth C. Anderson - National Academy of Sciences, Proceedings of the National Academy of Sciences 2002 被引用: 748

  20. Guideline for the diagnosis, treatment and response criteria for Bing-Neel syndrome

    著者: Monique C. Minnema, Eva Kimby, Shirley D’Sa, Luc‐Matthieu Fornecker, Stéphanie Poulain, Tom J. Snijders, Efstathios Kastritis, Stéphane Kremer, Aikaterini Fitsiori, Laurence Simon, Frédéric Davi, Michael P. Lunn, Jorge J. Castillo, Christopher J. Patterson, Magali Le Garff‐Tavernier, Myrto Costopoulos, Véronique Leblond, Marie José Kersten, Meletios Α. Dimopoulos, Steven P. Treon - Haematologica 2016 被引用: 152

  21. Central nervous system involvement by Waldenström macroglobulinaemia (Bing‐Neel syndrome): a multi‐institutional retrospective study

    著者: Jorge J. Castillo, Shirley D’Sa, Michael P. Lunn, Monique C. Minnema, Alessandra Tedeschi, Frederick Lansigan, M. Lia Palomba, Marzia Varettoni, Ramón García‐Sánz, Lakshmi Nayak, Eudocia Q. Lee, Mikael L. Rinne, Andrew D. Norden, Irene M. Ghobrial, Steven P. Treon - British Journal of Haematology 2015 被引用: 110

  22. Ibrutinib for the treatment of Bing-Neel syndrome: a multicenter study

    著者: Jorge J. Castillo, Gilad Itchaki, Jonas Paludo, Marzia Varettoni, Christian Buske, Toby A. Eyre, Julio C. Chávez, Kenneth H. Shain, Samar Issa, M. Lia Palomba, Oren Pasvolsky, David Simpson, Dipti Talaulikar, Constantine S. Tam, Alessandra Tedeschi, Stephen M. Ansell, Lakshmi Nayak, Steven P. Treon - Blood 2018 被引用: 100

  23. Progression Risk Stratification of Asymptomatic Waldenström Macroglobulinemia

    著者: Mark Bustoros, Romanos Sklavenitis‐Pistofidis, Prashant Kapoor, Chia‐Jen Liu, Efstathios Kastritis, Saurabh Zanwar, Geoffrey Fell, Jithma P. Abeykoon, Kalvis Hornburg, Carl Jannes Neuse, Catherine R. Marinac, David Liu, Jenny Soiffer, Maria Gavriatopoulou, Cody J. Boehner, Joseph M. Cappuccio, Henry Dumke, Kaitlen Reyes, Robert J. Soiffer, Robert A. Kyle, Steven P. Treon, Jorge J. Castillo, Meletios Α. Dimopoulos, Stephen M. Ansell, Lorenzo Trippa, Irene M. Ghobrial - Journal of Clinical Oncology 2019 被引用: 97

  24. Venetoclax in Previously Treated Waldenström Macroglobulinemia

    著者: Jorge J. Castillo, John N. Allan, Tanya Siddiqi, Ranjana H. Advani, Kirsten Meid, Carly Leventoff, Timothy P. White, Catherine A. Flynn, Shayna Sarosiek, Andrew R. Branagan, Maria G. Demos, Maria L. Guerrera, Amanda Kofides, Xia Liu, Manit Munshi, Nicholas Tsakmaklis, Lian Xu, Guang Yang, Christopher J. Patterson, Zachary R. Hunter, Matthew S. Davids, Richard R. Furman, Steven P. Treon - Journal of Clinical Oncology 2021 被引用: 87